169 related articles for article (PubMed ID: 15297081)
41. Probiotics for treatment of acute diarrhoea in children: randomised clinical trial of five different preparations.
Canani RB; Cirillo P; Terrin G; Cesarano L; Spagnuolo MI; De Vincenzo A; Albano F; Passariello A; De Marco G; Manguso F; Guarino A
BMJ; 2007 Aug; 335(7615):340. PubMed ID: 17690340
[TBL] [Abstract][Full Text] [Related]
42. Lactobacillus and bifidobacterium in irritable bowel syndrome: symptom responses and relationship to cytokine profiles.
O'Mahony L; McCarthy J; Kelly P; Hurley G; Luo F; Chen K; O'Sullivan GC; Kiely B; Collins JK; Shanahan F; Quigley EM
Gastroenterology; 2005 Mar; 128(3):541-51. PubMed ID: 15765388
[TBL] [Abstract][Full Text] [Related]
43. Effects of synbiotic fermented milk containing Lactobacillus acidophilus La-5 and Bifidobacterium animalis ssp. lactis BB-12 on the fecal microbiota of adults with irritable bowel syndrome: A randomized double-blind, placebo-controlled trial.
Bogovič Matijašić B; Obermajer T; Lipoglavšek L; Sernel T; Locatelli I; Kos M; Šmid A; Rogelj I
J Dairy Sci; 2016 Jul; 99(7):5008-5021. PubMed ID: 27157575
[TBL] [Abstract][Full Text] [Related]
44. Impact of Bifidobacterium animalis subsp. lactis BB-12 and, Lactobacillus acidophilus LA-5-containing yoghurt, on fecal bacterial counts of healthy adults.
Savard P; Lamarche B; Paradis ME; Thiboutot H; Laurin É; Roy D
Int J Food Microbiol; 2011 Sep; 149(1):50-7. PubMed ID: 21296446
[TBL] [Abstract][Full Text] [Related]
45. Oral probiotic and prevention of Pseudomonas aeruginosa infections: a randomized, double-blind, placebo-controlled pilot study in intensive care unit patients.
Forestier C; Guelon D; Cluytens V; Gillart T; Sirot J; De Champs C
Crit Care; 2008; 12(3):R69. PubMed ID: 18489775
[TBL] [Abstract][Full Text] [Related]
46. Association of early dietary fiber intake and mortality in septic patients with mechanical ventilation based on MIMIC IV 2.1 database: a cohort study.
Wang X; Miao S; Yang Y; Yang Q; Meng D; Liang H
Nutr J; 2024 Jan; 23(1):1. PubMed ID: 38167155
[TBL] [Abstract][Full Text] [Related]
47. Intestinal Microbiotas and Alcoholic Hepatitis: Pathogenesis and Therapeutic Value.
Zheng J; Li Z; Xu H
Int J Mol Sci; 2023 Sep; 24(19):. PubMed ID: 37834256
[TBL] [Abstract][Full Text] [Related]
48. Efficacy of probiotics or synbiotics for critically ill adult patients: a systematic review and meta-analysis of randomized controlled trials.
Wang K; Zeng Q; Li KX; Wang Y; Wang L; Sun MW; Zeng J; Jiang H
Burns Trauma; 2022; 10():tkac004. PubMed ID: 35291228
[TBL] [Abstract][Full Text] [Related]
49. Overview of the Importance of Biotics in Gut Barrier Integrity.
Kocot AM; Jarocka-Cyrta E; Drabińska N
Int J Mol Sci; 2022 Mar; 23(5):. PubMed ID: 35270039
[TBL] [Abstract][Full Text] [Related]
50. Production of a Class IIb Bacteriocin with Broad-spectrum Antimicrobial Activity in Lactiplantibacillus plantarum RUB1.
Wu A; Fu Y; Kong L; Shen Q; Liu M; Zeng X; Wu Z; Guo Y; Pan D
Probiotics Antimicrob Proteins; 2021 Dec; 13(6):1820-1832. PubMed ID: 34423377
[TBL] [Abstract][Full Text] [Related]
51. Synbiotic Therapy Prevents Nosocomial Infection in Critically Ill Adult Patients: A Systematic Review and Network Meta-Analysis of Randomized Controlled Trials Based on a Bayesian Framework.
Li C; Liu L; Gao Z; Zhang J; Chen H; Ma S; Liu A; Mo M; Wu C; Chen D; Liu S; Xie J; Huang Y; Qiu H; Yang Y
Front Med (Lausanne); 2021; 8():693188. PubMed ID: 34336896
[No Abstract] [Full Text] [Related]
52. Mining genome traits that determine the different gut colonization potential of
Xiao Y; Zhao J; Zhang H; Zhai Q; Chen W
Microb Genom; 2021 Jun; 7(6):. PubMed ID: 34100697
[TBL] [Abstract][Full Text] [Related]
53. The aging gut microbiome and its impact on host immunity.
Bosco N; Noti M
Genes Immun; 2021 Oct; 22(5-6):289-303. PubMed ID: 33875817
[TBL] [Abstract][Full Text] [Related]
54. Effects of Probiotics in Conditions or Infections Similar to COVID-19 on Health Outcomes: An Evidence Analysis Center Scoping Review.
Rozga M; Cheng FW; Handu D
J Acad Nutr Diet; 2021 Sep; 121(9):1841-1854. PubMed ID: 32807723
[TBL] [Abstract][Full Text] [Related]
55. Impact of microbiome-based interventions on gastrointestinal pathogen colonization in the intensive care unit.
Choy A; Freedberg DE
Therap Adv Gastroenterol; 2020; 13():1756284820939447. PubMed ID: 32733601
[TBL] [Abstract][Full Text] [Related]
56. Intestinal Permeability in Children with Celiac Disease after the Administration of Oligofructose-Enriched Inulin into a Gluten-Free Diet-Results of a Randomized, Placebo-Controlled, Pilot Trial.
Drabińska N; Krupa-Kozak U; Jarocka-Cyrta E
Nutrients; 2020 Jun; 12(6):. PubMed ID: 32531982
[TBL] [Abstract][Full Text] [Related]
57. The Importance of the Microbiome in Critically Ill Patients: Role of Nutrition.
Moron R; Galvez J; Colmenero M; Anderson P; Cabeza J; Rodriguez-Cabezas ME
Nutrients; 2019 Dec; 11(12):. PubMed ID: 31817895
[TBL] [Abstract][Full Text] [Related]
58. Impact of Soluble Fiber in the Microbiome and Outcomes in Critically Ill Patients.
Venegas-Borsellino C; Kwon M
Curr Nutr Rep; 2019 Dec; 8(4):347-355. PubMed ID: 31701433
[TBL] [Abstract][Full Text] [Related]
59. Infectious Threats, the Intestinal Barrier, and Its Trojan Horse: Dysbiosis.
Iacob S; Iacob DG
Front Microbiol; 2019; 10():1676. PubMed ID: 31447793
[TBL] [Abstract][Full Text] [Related]
60. Challenge to the Intestinal Mucosa During Sepsis.
Haussner F; Chakraborty S; Halbgebauer R; Huber-Lang M
Front Immunol; 2019; 10():891. PubMed ID: 31114571
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
